Filing Details
- Accession Number:
- 0000950170-23-052408
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-06 16:26:25
- Reporting Period:
- 2023-10-04
- Accepted Time:
- 2023-10-06 16:26:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840229 | Mink Therapeutics Inc. | INKT | Biological Products, (No Disgnostic Substances) (2836) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1098972 | Agenus Inc | 3 Forbes Road Lexington MA 02421 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-10-04 | 15,001 | $1.09 | 21,749,888 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Open market purchases reported on this line occurred at a weighted average price of $1.0919 (range of $1.02 to $1.10).
- Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
